Summary
Two cases of fatal pneumopathy during cytostatic therapy for acute lymphatic leukemia of childhood, are reported with pathoanatomical lung findings and general clinical features. Histology revealed massed atypical epithelial proliferation in the bronchiolar terminal pathways (tumourlets) with multinucleated polymorphic giant cells beside pulmonary fibrosis. As causative factors for pulmonary changes hypersensitivity reactions, direct toxicity, or pharmacologic effects are discussed. Formal pathogenesis is explained by an impairment of endothelial cells in alveolar capillaries followed by permeability disorders and interstitial edema with disturbed perfusion. Disseminated intravasal microthrombl are frequent. Restitution to integrity appears possible only under favorable conditions. If the exsudative turns into the proliferative phase, intraalveolar and interstitial pulmonary fibrosis may develop with atypical epithelial proliferations. The prognosis of cytostatics-induced pneumopathies depends essentially on the time when it is diagnosed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
André, R., Rochant, H., Dreyfus, B., duhamel, G., Pechere, J.: Fibrose interstitielle diffuse du poumon au cours d'une maladie de Hodgkin traitée par des doses élevées d'endoxan. Bull. Soc. Med. Hôp. (Paris) 118, 1133–1141 (1967)
burkhardt, A., Gebbers, J.O., Höltje, W.J.: Die Bleomycin-Lunge. Dtsch. Med. Wochenschr. 102, 281–289 (1977)
Clarysse, A.M., Cathey, W.J., Cartwright, G.E., Wintrobe, M.M.: Pulmonary disease complicating intermittent therapy with methotrexate. J. Am. Med. Ass. 209, 1861–1864 (1969)
Dietzsch, H.J., Lorenz, K., Roschlau, G.: Lungenveränderungen bei Methotrexat-Behandlung im Kindesalter. Dtsch. Gesundheitswesen 26, 174–178 (1971)
Everts, C.S., Westcott, J.L., Bragg, D.G.: Methotrexate therapy and pulmonary disease. Radiology 107, 539–543 (1973)
Filip, D.J., Logue, G.L., Harle T.S., Farrar, W.H.: Pulmonary and hepatic complications of methotrexate therapy of psoriasis. J. Am. Med. Ass. 216, 881–882 (1971)
Goldman, G.C., Moschella, S.L.: Severe pneumonitis occurring during therapy with methotrexate. Arch. Derm. 103, 194–197 (1971)
Holt, J.A.G.: The acute radiation pneumonitis syndrome. J. Coll. Radiol. Austr. 8, 40–47 (1964)
Kapanci, Y., Weibel, E.R., Kaplan, H.P., Robinson, F.R.: Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. Lab. Invest. 20, 101–118 (1969)
Koss, L.G., Melamed, M.R., Mayer, K.: The effect of Busulfan on human epithelia. Am. J. Clin. Pathol. 44, 385–397 (1965)
Mittermayer, C., Riede, U.N., Bleyl, U., Herzog, H., Wichert, P. von, Riesner, K.: Schocklunge. Verh. Dtsch. Ges. Pathol. 62, 11–65 (1978)
Müller, K.M., Grundmann, E.: Pathologisch-anatomische Veränderungen nach “akutem Lungenversagen”. In: Intensivmedizin-Notfallmedizin-Anaesthesiologie (eds.: Lawin, P., Loewenich, V.v., Rodewald, G., Schölmerich, P., Stoeckel, H.). Stuttgart: Thieme 1979 (im Druck)
Müller, U., Hoigné, R.: Lunge und Nitrofurantoin. Dtsch. Med. Wochenschr. 96, 955–956 (1971)
Oliner, H., Schwartz, R., Rubio, F. Jr.: Interstitial pulmonary fibrosis following busulfan therapy. Am. J. Med. 31, 134–139 (1961)
Patel, A.R., Shah, P.C., Rhef, H.L.: Cyclophosphamide therapy and interstitial pulmonary fibrosis. Cancer 38, 1542–1549 (1976)
Pinkel, D., Simone, J., Hustu, H.O., Aur, R.J.A.: “Total therapy” of acute lymphocytic leukemia. Pediatrics 50, 246–251 (1972)
Riehm, H., Gadner, H., Welte, H.: Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin. Pädiatr. 189, 89–102 (1978)
Rodin, A.E., Haggard, M.E., Travis, L.B.: Lung changes and chemotherapeutic agents in childhood. Am. J. Dis. Child. 120, 337–340 (1970)
Rosenow, E.C.: The spectrum of drug-induced pulmonary disease. Ann. Intern. Med. 77, 977–991 (1972)
Sandritter, W., Mittermayer, C., Riede, U.N., Freudenberg, N., Grimm, H.: Shock lung sundrome. Pathol. Res. Pract. 162, 7–23 (1978)
Sauer, E., Gulotta, U., Fink, U.: Akute beidseitige Lungeninfiltration als Komplikation der zytostatischen Therapie. Dtsch. Med. Wochenschr. 100, 2098–2101 (1975)
Schwartz, J.R., Kajani, M.K.: Methotrexate therapy and pulmonary disease. J. Am. Med. Ass. 210, 1924 (1969)
Shastri, S., Slayton, R.E., Walter, J., Perlia, C.P., Taylor, S.G.: Clinical study with bleomycin. Cancer 28, 1142–1146 (1971)
Uthgenannt, H., Lübbers, P., Gappmayer, K.: Allergische Reaktionen der Lunge durch Arzneimittel. Fortschr. Röntgenstr. 118, 125–136 (1973)
Waller, U.: Riesenkerne nach Mylerantherapie (Busulfan) und Milzbestrahlung bei chronisch-myeloischer Leukämie. Pathol. Microbiol. 23, 283–290 (1960)
Weibel, E.R.: Toxische Auswirkungen erhöhter Sauerstoffspannung auf die Lunge. In: Lungenveränderungen bei Langzeitbeatmung (Hrsg.: K. Wiemers, K.L. Schoeller), S. 214–223. Stuttgart: Thieme 1971
Weston, J.R., Guin, G.H.: Epithelial atypias with chemotherapy in 100 acute childhood leukemias. Cancer 8, 179–186 (1955)
Whitcomb, M.E., Schwarz, M.I., Tormey, D.C.: Methotrexate pneumonitis: case report and review of the literature. Thorax 27, 636–639 (1972)
Wichert, P. von, Hain, E.: Alveolitiden und Lungenfibrosen—Versuch einer Synopsis. Internist 15, 370–378 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, K.M., Menne, R., Hüther, W. et al. Fatal pneumopathy after cytostatic treatment for leukemia in children. J Cancer Res Clin Oncol 94, 287–294 (1979). https://doi.org/10.1007/BF00419288
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00419288